UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification

Leukemia, 2024-02, Vol.38 (2), p.442-445

2024

Volltextzugriff (PDF)

Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid

Blood, 2004-09, Vol.104 (5), p.1266-1269

2004

Volltextzugriff (PDF)

Thalidomide for the treatment of patients with myelodysplastic syndromes

Leukemia, 2002, Vol.16 (1), p.1-6

2002

Volltextzugriff (PDF)

P772: PROGNOSTIC IMPACT OF DISEASE‐RELATED RISK FACTORS AND TREATMENT APPROACHES IN PATIENTS WITH ADVANCED MYELODYSPLASTIC SYNDROMES (MDS)

HemaSphere, 2022-06, Vol.6, p.667-668

2022

Volltextzugriff (PDF)

Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS)

Leukemia, 2005-12, Vol.19 (12), p.2223-2231

2005

Volltextzugriff (PDF)

P771: PROGNOSTIC CHARACTERISTICS OF PATIENTS WITH MDS WITH ABERRATIONS OF CHROMOSOME 5. DATA FROM THE DÜSSELDORF MDS REGISTRY

HemaSphere, 2022-06, Vol.6, p.666-667

2022

Volltextzugriff (PDF)

W. Otterspeer (ed.), De hand van Huizinga

Bijdragen en mededelingen betreffende de geschiedenis der Nederlanden, 2011-01, Vol.126 (2), p.138-139

Strupp, C.

2011

Volltextzugriff (PDF)

Chronic myelomonocytic leukemia in the light of the WHO proposals

Haematologica (Roma), 2007-07, Vol.92 (7), p.974-977

2007

Volltextzugriff (PDF)

Improvement of criteria for refractory cytopenia with multilineage dysplasia according to the WHO classification based on prognostic significance of morphological features in patients with refractory anemia according to the FAB classification

Leukemia, 2007-04, Vol.21 (4), p.678-686

2007

Volltextzugriff (PDF)

Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome

Haematologica (Roma), 2011-03, Vol.96 (3), p.441-449

2011

Volltextzugriff (PDF)

Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)

Haematologica (Roma), 2011-10, Vol.96 (10), p.1433-1440

2011

Volltextzugriff (PDF)

Cytogenetic response to thalidomide treatment in three patients with myelodysplastic syndrome

Leukemia, 2003-06, Vol.17 (6), p.1200-1202

2003

Volltextzugriff (PDF)

The myelodysplastic syndrome-comorbidity index provides additional prognostic information on patients stratified according to the revised international prognostic scoring system

Haematologica (Roma), 2014-03, Vol.99 (3), p.e31-e32

2014

Volltextzugriff (PDF)

The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome

Haematologica (Roma), 2009-05, Vol.94 (5), p.729-732

2009

Volltextzugriff (PDF)

W. Otterspeer (ed.), De hand van Huizinga

Bijdragen en mededelingen betreffende de geschiedenis der Nederlanden, 2011-01, Vol.126 (2), p.138-139

C. Strupp

2011

Volltextzugriff (PDF)

W. Otterspeer (ed.), De hand van Huizinga

Bijdragen en mededelingen betreffende de geschiedenis der Nederlanden, 2011-01, Vol.126 (2)

C. Strupp

2011

Volltextzugriff (PDF)

W. Otterspeer (ed.), De hand van Huizinga

Bijdragen en mededelingen betreffende de geschiedenis der Nederlanden, 2011-01, Vol.126 (2)

C. Strupp

2011

Volltextzugriff (PDF)

Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes

Haematologica (Roma), 2006-12, Vol.91 (12), p.1596-1604

2006

Volltextzugriff (PDF)

Single-agent thalidomide for treatment of first relapse following high-dose chemotherapy in patients with multiple myeloma

Leukemia, 2005-01, Vol.19 (1), p.156-159

2005

Volltextzugriff (PDF)

No increase in age-specific incidence of myelodysplastic syndromes

Haematologica (Roma), 2004-08, Vol.89 (8), p.905

2004

Volltextzugriff (PDF)

Transdermal fentanyl during high-dose chemotherapy and autologous stem cell support

Oncology reports, 2000-05, Vol.7 (3), p.659

2000

Volltextzugriff (PDF)

Monitoring Enzyme Catalysis with Mass Spectrometry

The Journal of biological chemistry, 2000-05, Vol.275 (18), p.13455-13459

2000

Volltextzugriff (PDF)

Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposals

British journal of haematology, 2006-01, Vol.132 (2), p.162-167

2006

Volltextzugriff (PDF)

Refinement of the international prognostic scoring system

Leukemia, 2005-12, Vol.19 (12), p.2223

2005

Volltextzugriff (PDF)

Thalidomide for the treatment of patients with myelodysplastic syndromes

Leukemia, 2002-01, Vol.16 (1), p.1

2002

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Aktive Filter

KollektionEZB Free E-Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(82)

Publikationsform

Sprache

Englisch
(86)
Französisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(68)
Humans
(56)
Life Sciences & Biomedicine
(55)
Female
(37)
Male
(35)
Middle Aged
(33)
Adult
(29)
Biological And Medical Sciences
(24)
Aged
(23)
Medical Sciences
(23)
Neurosciences & Neurology
(21)
Multidisciplinary Sciences
(20)
Science & Technology - Other Topics
(20)
Clinical Neurology
(17)
Hematology
(16)
Aged, 80 And Over
(15)
Neurosciences
(14)
Hematologic And Hematopoietic Diseases
(12)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(12)
Animals
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification

Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid

Thalidomide for the treatment of patients with myelodysplastic syndromes

P772: PROGNOSTIC IMPACT OF DISEASE‐RELATED RISK FACTORS AND TREATMENT APPROACHES IN PATIENTS WITH ADVANCED MYELODYSPLASTIC SYNDROMES (MDS)

Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS)

P771: PROGNOSTIC CHARACTERISTICS OF PATIENTS WITH MDS WITH ABERRATIONS OF CHROMOSOME 5. DATA FROM THE DÜSSELDORF MDS REGISTRY

W. Otterspeer (ed.), De hand van Huizinga

Chronic myelomonocytic leukemia in the light of the WHO proposals

Improvement of criteria for refractory cytopenia with multilineage dysplasia according to the WHO classification based on prognostic significance of morphological features in patients with refractory anemia according to the FAB classification

Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome

Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)

Cytogenetic response to thalidomide treatment in three patients with myelodysplastic syndrome

The myelodysplastic syndrome-comorbidity index provides additional prognostic information on patients stratified according to the revised international prognostic scoring system

The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome

W. Otterspeer (ed.), De hand van Huizinga

W. Otterspeer (ed.), De hand van Huizinga

W. Otterspeer (ed.), De hand van Huizinga

Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes

Single-agent thalidomide for treatment of first relapse following high-dose chemotherapy in patients with multiple myeloma

No increase in age-specific incidence of myelodysplastic syndromes

Transdermal fentanyl during high-dose chemotherapy and autologous stem cell support

Monitoring Enzyme Catalysis with Mass Spectrometry

Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposals

Refinement of the international prognostic scoring system

Thalidomide for the treatment of patients with myelodysplastic syndromes

Aktive Filter

Suchergebnisse filtern